COHERUS BIOSCIENCES I
0.8200
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.0962
+13.29%
Today's range
0.7610 - 0.9550
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
05 Aug 2024 09:45:04 By NetDania Notify
-
Coherus to Report Second Quarter 2024 Financial Results on August 8, 2024
01 Aug 2024 09:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
08 Jul 2024 09:58:08 By NetDania Notify
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
05 Jul 2024 09:50:52 By NetDania Notify
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
03 Jul 2024 09:46:52 By NetDania Notify
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
02 Jul 2024 11:28:48 By NetDania Notify
-
27 Jun 2024 08:26:59 By Nasdaq GlobeNewswire
-
Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
05 Jun 2024 09:00:00 By Nasdaq GlobeNewswire
-
Coherus Management to Present at the 2024 Jefferies Global Healthcare Conference
30 May 2024 09:00:00 By Nasdaq GlobeNewswire
-
23 May 2024 09:00:00 By Nasdaq GlobeNewswire
-
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 16:01:00 By Nasdaq GlobeNewswire
-
Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
09 May 2024 07:30:00 By Nasdaq GlobeNewswire
-
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
01 May 2024 16:30:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 10:02:18 By Nasdaq GlobeNewswire
-
08 Apr 2024 08:30:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
05 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
Coherus Completes Divestiture of Ophthalmology Franchise
04 Mar 2024 01:00:00 By Nasdaq GlobeNewswire